Cargando…

TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway

BACKGROUND: Transmembrane emp24 domain containing (TMED) proteins are known to play pivotal roles in normal development, but have been reported to be implicated in pancreatic disease, immune system disorders, and cancers. As far as TMED3 is concerned, its roles in cancers are controversial. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Xianling, Yin, Xiaolan, Xu, Yu, Li, Liang, Yuan, Min, Zhao, Huaxin, Jiang, Yuxiong, Shi, Xiujuan, Bi, Hongda, Liu, Yeqiang, Chen, Yong, Xu, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053972/ https://www.ncbi.nlm.nih.gov/pubmed/36991473 http://dx.doi.org/10.1186/s13578-023-01006-6

Ejemplares similares

CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway
por: Feng, Sitong, et al.
Publicado: (2023)

TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5
por: Jin, Xiaoying, et al.
Publicado: (2022)

TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways
por: Chen, Jiangyan, et al.
Publicado: (2021)

Depleting TMED3 alleviates the development of endometrial carcinoma
por: Zhang, Jin, et al.
Publicado: (2022)

CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation
por: Fu, Guanghou, et al.
Publicado: (2020)

The multi-faceted roles of the PI3K-AKT pathway in melanoma
por: Davies, Michael A
Publicado: (2015)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

Expression of TMED3 is independently associated with colorectal cancer prognosis
por: Wang, Rong-Fei, et al.
Publicado: (2022)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

TMED3/RPS15A Axis promotes the development and progression of osteosarcoma
por: Xu, Wei, et al.
Publicado: (2021)

The circular RNA CDR1as regulate cell proliferation via TMED2 and TMED10
por: Yang, Xue, et al.
Publicado: (2020)

RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
por: Yajima, Ichiro, et al.
Publicado: (2012)

KLF10 upregulates ACSM3 via the PI3K/Akt signaling pathway to inhibit the malignant progression of melanoma
por: Zhao, Zhirong, et al.
Publicado: (2022)

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

Insulin induces drug resistance in melanoma through activation of the PI3K/Akt pathway
por: Chi, Mengna, et al.
Publicado: (2014)

TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR
por: Xie, An, et al.
Publicado: (2021)

RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma
por: Laugier, Florence, et al.
Publicado: (2015)

Trafficking protein TMED3 promotes esophageal squamous cell carcinoma
por: Yang, Yuxian, et al.
Publicado: (2023)

Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer
por: Fang, Zheng, et al.
Publicado: (2022)

Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
por: Jiang, Ningni, et al.
Publicado: (2020)

Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
por: Pappalardo, Francesco, et al.
Publicado: (2016)

Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down‐regulating PI3K/AKT pathway
por: Wang, Chenjie, et al.
Publicado: (2019)

The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases
por: Mishra, Sonakshi, et al.
Publicado: (2019)

TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
por: Zheng, Hao, et al.
Publicado: (2016)

Unconventional secretion: cargo channeling by TMED10
por: Nguyen, Tan A., et al.
Publicado: (2020)

TMED family genes and their roles in human diseases
por: Zhou, Lv, et al.
Publicado: (2023)

MDA-19 Suppresses Progression of Melanoma Via Inhibiting the PI3K/Akt Pathway
por: Dang, Ningning, et al.
Publicado: (2018)

AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway
por: Tian, Ke, et al.
Publicado: (2023)

KIF26B Is Overexpressed in Medulloblastoma and Promotes Malignant Progression by Activating the PI3K/AKT Pathway
por: Liu, Yajun, et al.
Publicado: (2022)

TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling
por: Dai, Youyi, et al.
Publicado: (2017)

Lyn Kinase Promotes the Proliferation of Malignant Melanoma Cells through Inhibition of Apoptosis and Autophagy via the PI3K/Akt Signaling Pathway
por: Zhang, Qianqian, et al.
Publicado: (2019)

TMED2 promotes epithelial ovarian cancer growth
por: Shi-Peng, Gong, et al.
Publicado: (2017)

Expression and Importance of TMED2 in Multiple Myeloma Cells
por: Ge, Xueling, et al.
Publicado: (2020)

Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma
por: Oliveira, Camila S, et al.
Publicado: (2014)

Upregulation of miR-29c-3p Hinders Melanoma Progression by Inhibiting CDCA4 Expression
por: Liu, Jiazheng, et al.
Publicado: (2021)

Roxarsone induces angiogenesis via PI3K/Akt signaling
por: Wang, Yujing, et al.
Publicado: (2016)

Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells
por: Yang, Jinxing, et al.
Publicado: (2021)

PI3K/AKT Pathway and Brain Malformations
por: Rice, Gavin B., et al.
Publicado: (2015)

PI3K and AKT: Unfaithful Partners in Cancer
por: Faes, Seraina, et al.
Publicado: (2015)

The PI3K/Akt Pathway in Meta-Inflammation
por: Acosta-Martinez, Maricedes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2pulim2cboia4dn1gl6hjh3mbl